Ching W. Jaw's Insider Trades & SAST Disclosures
Ching W. Jaw's most recent trade in Cytokinetics Inc was a trade of 47,445 Non-Qualified Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 6, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Ching W. Jaw.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cytokinetics Inc | Ching W. Jaw | SVP Finance & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 47,445 | 47,445 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Cytokinetics Inc | Ching W. Jaw | SVP Finance & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 30,000 | 87,346 (0%) | 0% | 0 | Common Stock | |
| Cytokinetics Inc | Ching W. Jaw | SVP Finance & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 2,555 | 2,555 | - | - | Incentive Stock Option (Right to Buy) | |
| Cytokinetics Inc | Ching W. Jaw | SVP Finance & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.13 per share. | 06 Mar 2023 | 2,403 | 57,346 (0%) | 0% | 39.1 | 94,029 | Common Stock |
| Cytokinetics Inc | Ching W. Jaw | SVP Finance & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.60 per share. | 02 Mar 2023 | 6,225 | 59,749 (0%) | 0% | 39.6 | 246,510 | Common Stock |
| Cytokinetics Inc | Ching W. Jaw | SVP Finance & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.13 per share. | 16 Feb 2023 | 1,210 | 65,974 (0%) | 0% | 44.1 | 53,397 | Common Stock |
| Cytokinetics Inc | Ching W. Jaw | SVP Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 15,000 | 3,056 | - | - | Incentive Stock Option (Right to Buy) | |
| Cytokinetics Inc | Ching W. Jaw | SVP Finance & CFO | Sale of securities on an exchange or to another person at price $ 45.00 per share. | 03 Feb 2023 | 15,000 | 67,184 (0%) | 0% | 45 | 675,000 | Common Stock |
| Cytokinetics Inc | Ching W. Jaw | SVP Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.10 per share. | 03 Feb 2023 | 15,000 | 82,184 (0%) | 0% | 12.1 | 181,500 | Common Stock |
| Cytokinetics Inc | Ching W. Jaw | SVP Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.10 per share. | 04 Apr 2022 | 15,000 | 82,109 (0%) | 0% | 12.1 | 181,500 | Common Stock |
| Cytokinetics Inc | Ching W. Jaw | SVP Finance & CFO | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 04 Apr 2022 | 15,000 | 67,109 (0%) | 0% | 40 | 600,000 | Common Stock |
| Cytokinetics Inc | Ching W. Jaw | SVP Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2022 | 15,000 | 11,944 | - | - | Non-Qualified Stock Option (right to buy) | |
| Cytokinetics Inc | Ching W. Jaw | SVP Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2022 | 10,000 | 1,944 | - | - | Non-Qualified Stock Option (right to buy) | |
| Cytokinetics Inc | Ching W. Jaw | SVP Finance & CFO | Sale of securities on an exchange or to another person at price $ 42.00 per share. | 04 Apr 2022 | 10,000 | 67,109 (0%) | 0% | 42 | 420,000 | Common Stock |
| Cytokinetics Inc | Ching W. Jaw | SVP Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.10 per share. | 04 Apr 2022 | 10,000 | 77,109 (0%) | 0% | 12.1 | 121,000 | Common Stock |
| Cytokinetics Inc | Ching W. Jaw | SVP Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2022 | 15,000 | 26,944 | - | - | Non-Qualified Stock Option (right to buy) | |
| Cytokinetics Inc | Ching W. Jaw | SVP Finance & CFO | Sale of securities on an exchange or to another person at price $ 38.00 per share. | 09 Mar 2022 | 15,000 | 67,109 (0%) | 0% | 38 | 570,000 | Common Stock |
| Cytokinetics Inc | Ching W. Jaw | SVP Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.10 per share. | 09 Mar 2022 | 15,000 | 82,109 (0%) | 0% | 12.1 | 181,500 | Common Stock |
| Cytokinetics Inc | Ching W. Jaw | SVP Finance & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.83 per share. | 07 Mar 2022 | 5,510 | 67,109 (0%) | 0% | 36.8 | 202,933 | Common Stock |
| Cytokinetics Inc | Ching W. Jaw | SVP Finance & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 46,138 | 46,138 | - | - | Non-Qualified Stock Option (right to buy) | |
| Cytokinetics Inc | Ching W. Jaw | SVP Finance & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 20,000 | 72,619 (0%) | 0% | 0 | Common Stock | |
| Cytokinetics Inc | Ching W. Jaw | SVP Finance & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 3,862 | 3,862 | - | - | Incentive Stock Option (right to buy) | |
| Cytokinetics Inc | Ching W. Jaw | SVP Finance & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.63 per share. | 02 Mar 2022 | 3,458 | 52,619 (0%) | 0% | 37.6 | 130,125 | Common Stock |
| Cytokinetics Inc | Ching W. Jaw | SVP Finance & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.32 per share. | 28 Feb 2022 | 2,074 | 56,077 (0%) | 0% | 35.3 | 73,254 | Common Stock |
| Cytokinetics Inc | Ching W. Jaw | SVP Finance & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2022 | 3,125 | 58,151 (0%) | 0% | 0 | Common Stock | |
| Cytokinetics Inc | Ching W. Jaw | SVP Finance & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2022 | 1,897 | 55,026 (0%) | 0% | 0 | Common Stock | |
| Cytokinetics Inc | Ching W. Jaw | SVP Finance & CFO | Sale of securities on an exchange or to another person at price $ 35.73 per share. | 19 Oct 2021 | 35,687 | 53,064 (0%) | 0% | 35.7 | 1,275,186 | Common Stock |
| Cytokinetics Inc | Ching W. Jaw | SVP Finance & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.19 per share. | 08 Mar 2021 | 4,150 | 88,492 (0%) | 0% | 19.2 | 79,639 | Common Stock |
| Cytokinetics Inc | Ching W. Jaw | SVP Finance & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 34,879 | 34,879 | - | - | Non-Qualified Stock Option (right to buy) | |
| Cytokinetics Inc | Ching W. Jaw | SVP Finance & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 25,000 | 92,642 (0%) | 0% | 0 | Common Stock | |
| Cytokinetics Inc | Ching W. Jaw | SVP Finance & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 10,121 | 10,121 | - | - | Incentive Stock Option (right to buy) | |
| Cytokinetics Inc | Ching W. Jaw | SVP Finance & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.66 per share. | 01 Mar 2021 | 1,384 | 67,642 (0%) | 0% | 19.7 | 27,209 | Common Stock |
| Cytokinetics Inc | Ching W. Jaw | SVP Finance & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.73 per share. | 26 Feb 2021 | 4,353 | 69,026 (0%) | 0% | 18.7 | 81,532 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges